Rickettsiosis
Rickettsiae belong to the alpha-1 proteobacteria which are small gram-negative intracellular bacteria majorly transmitted by arthropods such as lice, fleas, ticks with two genera: Orientia with a unique specie and Rickettsia with several species. The clinical pictures which cause are known to be rickettsioses. All along the history, rickettsioses have been a threat and nowadays they are specifically cause of morbi-mortality in some areas of the world. Currently, ticks cause most travel-associated rickettsioses. Ticks are considered as one of the important vectors of infectious diseases in the world, preceded only by mosquitoes. Therefore, tick-borne rickettsioses are endemic all over the globe.
- Spotted fever group
- Typhus group
- Scrub typhus group
Related Conference of Rickettsiosis
11th World Congress and Exhibition on Antibiotics and Antibiotic Resistance
5th International conference on Vaccines, Vaccination and Immunization
Rickettsiosis Conference Speakers
Recommended Sessions
Related Journals
Are you interested in
- Antibiotic Prophylaxis - Antibiotics 2024 (UK)
- Antibiotic Resistance: Opportunities and Challenges - Antibiotics 2024 (UK)
- Antibiotic-resistant Bacterial infections - Antibiotics 2024 (UK)
- Antibiotics - Antibiotics 2024 (UK)
- Antibiotics for Various Diseases and Infections - Antibiotics 2024 (UK)
- Antibiotics: In Pregnancy and Lactation - Antibiotics 2024 (UK)
- Antimicrobial Peptides - Antibiotics 2024 (UK)
- Antimicrobial Therapy - Antibiotics 2024 (UK)
- Cancer Immunology and Immunotherapy - IMMUNOLOGY 2024 (Spain)
- Cell & Plant Biology - IMMUNOLOGY 2024 (Spain)
- Cell Biology - IMMUNOLOGY 2024 (Spain)
- CELL, ANIMAL & PLANT BIOLOGY - IMMUNOLOGY 2024 (Spain)
- Clinical Immunology & Current & Future Research - IMMUNOLOGY 2024 (Spain)
- Clinical Trials of Antibiotics - Antibiotics 2024 (UK)
- Current research in antibiotic resistance - Antibiotics 2024 (UK)
- Developing Alternatives to Antibiotics - Antibiotics 2024 (UK)
- Drug Discovery and Novel Delivery Technologies - Antibiotics 2024 (UK)
- Immune System - IMMUNOLOGY 2024 (Spain)
- Immuno informatics & Systems immunology - IMMUNOLOGY 2024 (Spain)
- Immuno-Genetics - IMMUNOLOGY 2024 (Spain)
- Immunogenetics - IMMUNOLOGY 2024 (Spain)
- Immunohistochemistry - IMMUNOLOGY 2024 (Spain)
- Immunology - IMMUNOLOGY 2024 (Spain)
- Immunology & Vaccines - Antibiotics 2024 (UK)
- Immunotherapy - IMMUNOLOGY 2024 (Spain)
- Infectious Diseases - Antibiotics 2024 (UK)
- Mechanism and Evolution of Antibiotic Resistance - Antibiotics 2024 (UK)
- Micro Organisms in Recent Drug Discovery - Antibiotics 2024 (UK)
- Microorganisms Producing Antibiotics - Antibiotics 2024 (UK)
- Modern Antibiotics for Various Diseases and Infections - Antibiotics 2024 (UK)
- New antibiotics and non-antibiotic approaches - Antibiotics 2024 (UK)
- Nutritional Immunology - IMMUNOLOGY 2024 (Spain)
- OncoImmunology - IMMUNOLOGY 2024 (Spain)
- Pediatric and Neonatal Immunology - IMMUNOLOGY 2024 (Spain)
- Pharmacokinetics and Pharmacodynamics of Antimicrobial Drugs - Antibiotics 2024 (UK)
- Pharmacology & Toxicology - Antibiotics 2024 (UK)
- Prevention and Control of Antibiotic Resistance - Antibiotics 2024 (UK)
- Reproductive Immunology - IMMUNOLOGY 2024 (Spain)
- The Next Generation Approach of Antibiotics - Antibiotics 2024 (UK)
- Transplantation and Computational Immunology - IMMUNOLOGY 2024 (Spain)
- Vaccines & Immunization - IMMUNOLOGY 2024 (Spain)
- Virology and infectious diseases - IMMUNOLOGY 2024 (Spain)